SILENT THYROID, RARE BUT REAL. OCULAR MANIFESTATION OF EUTHYROID GRAVES EYE DISEASE, PERSPECTIVE OF OCULOPLASTIC CENTER.
Insights-Journal of Health and Rehabilitation · 2025
DOI: 10.71000/05jrbz17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Insights-Journal of Health and Rehabilitation, 2025. Verfasst von Nuzhat Rahil und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Euthyroid Graves’ disease (EGD) is a rare manifestation of thyroid-associated ophthalmopathy (TAO) occurring in patients with normal thyroid function. While TAO is well-documented in hyperthyroid patients, the characteristics and progression of EGD remain under-researched due to its low prevalence. Delays in diagnosis are common as patients lack systemic thyroid symptoms, and its clinical presentation often overlaps with other orbital pathologies. Early recognition of EGD is critical to preventing vision-threatening complications and reducing morbidity.
Objective
To determine the clinical signs and demographic distribution of EGD in patients attending a tertiary oculoplastic service.
Methods
A cross-sectional study was conducted at the Oculoplastic Center of Medical Teaching Institute, Lady Reading Hospital, Peshawar, from January 2019 to December 2020. All consecutive patients diagnosed with EGD based on clinical and radiological findings and normal thyroid function tests were included. Data on demographics and clinical features were collected and analyzed using SPSS version 25. Frequencies and percentages were used for categorical variables, and mean ± standard deviation was calculated for continuous variables such as age. Chi-square and t-tests were applied where relevant, with a p-value of 51 age group, 18 patients (38.7%) presented with eyelid retraction, followed by 12 (24.5%) with eyelid swelling. Optic neuropathy was identified in 4 cases (8.2%).
Conclusion
Upper eyelid retraction was the most frequent clinical sign in EGD, particularly in older females. Serious complications like optic neuropathy and myopathy underscore the importance of early identification and multidisciplinary management in euthyroid patients presenting with orbital symptoms.
Zitieren
APA
Rahil, N., Khan, B., Idris, M., Ali, R., Malik, M. A., & Israr, M. (2025). SILENT THYROID, RARE BUT REAL. OCULAR MANIFESTATION OF EUTHYROID GRAVES EYE DISEASE, PERSPECTIVE OF OCULOPLASTIC CENTER. Insights-Journal of Health and Rehabilitation. https://doi.org/10.71000/05jrbz17
Vancouver
Rahil N, Khan B, Idris M, Ali R, Malik MA, Israr M. SILENT THYROID, RARE BUT REAL. OCULAR MANIFESTATION OF EUTHYROID GRAVES EYE DISEASE, PERSPECTIVE OF OCULOPLASTIC CENTER. Insights-Journal of Health and Rehabilitation. 2025. doi:10.71000/05jrbz17
BibTeX
@article{Rahil2025,
author = {Rahil, Nuzhat and Khan, Bilal and Idris, Muhammad and Ali, Ramin and Malik, Muhammad Arib and Israr, Muhammad},
title = {SILENT THYROID, RARE BUT REAL. OCULAR MANIFESTATION OF EUTHYROID GRAVES EYE DISEASE, PERSPECTIVE OF OCULOPLASTIC CENTER},
journal = {Insights-Journal of Health and Rehabilitation},
year = {2025},
doi = {10.71000/05jrbz17}
}
EUVIMED